Catalyst Pharmaceuticals Stock Performance

Catalyst Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  2,341  in Catalyst Pharmaceuticals on November 27, 2025 and sell it today you would earn a total of  78.00  from holding Catalyst Pharmaceuticals or generate 3.33% return on investment over 90 days. Catalyst Pharmaceuticals is currently generating 0.0724% in daily expected returns and assumes 1.8505% risk (volatility on return distribution) over the 90 days horizon. In different words, 16% of stocks are less volatile than Catalyst, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 2.42 times more return on investment than the market. However, the company is 2.42 times more volatile than its market benchmark. It trades about 0.04 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

Catalyst Pharmaceuticals Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Catalyst Pharmaceuticals has a beta of 0.76 suggesting as returns on the market go up, Catalyst Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Catalyst Pharmaceuticals will be expected to be much smaller as well. Additionally Catalyst Pharmaceuticals has an alpha of 0.0359, implying that it can generate a 0.0359 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Catalyst Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Catalyst Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 22.32 24.17 26.02 Details

Intrinsic Valuation Low Real High 21.77 29.28 31.13 Details

Naive Forecast Low Next High 21.46 23.31 25.16 Details

7 Analysts Consensus Low Target High 31.46 34.57 38.37 Details

Catalyst Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Catalyst Pharmaceuticals is not an exception. The market had few large corrections towards the Catalyst Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Catalyst Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Catalyst Pharmaceuticals within the framework of very fundamental risk indicators.

Catalyst Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Catalyst Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Catalyst Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Catalyst Pharmaceuticals Price Density Drivers

Catalyst Pharmaceuticals Fundamentals Growth

When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.